Glycomics/Glycobiology Market Size Worth $2.1 Billion by 2025: Grand View Research, Inc.
SAN FRANCISCO, October 16, 2018 /PRNewswire/ --
The global glycomics/glycobiology market size is expected to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 14.4% over the forecast period. Rising focus on glycomics and proteomics research is driving the market. Huge investments have also enabled academic researchers to develop new glycobiology tools. This is a high-impact rendering driver for the market. As per many researchers, study on glycans helps understand biological processes more comprehensively, without specializing in glycobiology.
According to the 2017 BDO Biotech Briefing, the average R&D expenditure of mid-sized biotech companies has increased by around 18% from USD 65.9 million to USD 80.6 million during the span of 2015 to 2016. Growing drug discovery and development are leading to an increase in R&D investments by biotech companies. Thus, the need for glycomics research techniques to conduct comprehensive glycomes study is constantly growing.
Rise in number of initiatives being undertaken by the government to increase funding for research has led to the high need for glycomics techniques. For instance, the Australian government invested around USD 10 billion in scientific research and innovations for the period 2016 to 2017. The Irish Government also announced a USD 5.6 billion spending program in 2015 aimed at increasing the number of scientific research activities from 25,000 to 40,000 in the next 5 years. Such funding initiatives are expected to enhance demand for glycomics research techniques in near future.
Key players are also undertaking extensive R&D initiatives to develop new and technologically advanced products. For instance, in 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System, an integrated platform that enables user-friendly and high-throughput glycoanalysis. In 2018, Shimadzu Corporation collaborated with PREMIER Biosoft, a global player in bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis.
Browse full research report with TOC on "Glycomics/Glycobiology Market Analysis Report By Product (Instruments, Enzymes, Kits, Reagents), By Application (Drug Discover, Diagnostics), By End Use, By Region, And Segment Forecasts, 2018 - 2025" at:https://www.grandviewresearch.com/industry-analysis/glycobiology-market
Further Key Findings From the Report Suggest:
Enzymes was the fastest growing product segment of the glycomics/glycobiology market in 2017, due to repetitive purchase and rising application in research and diagnostics
In application segment, drug discovery and development accounted for the largest revenue share in 2017, owing to high focus on novel drug development and demand for personalized medicines
North America is anticipated to continue to lead the global market during the forecast period owing to existence of large number of research laboratories and pharmaceutical and biotechnology companies
Europe is expected to expand at the highest CAGR during the forecast period due to availability of advanced infrastructure coupled with rising number of pharmaceutical and biopharmaceutical companies
Some of the major market players include Danaher; ProZyme; Shimadzu Corporation; Agilent Technologies; Bruker; Merck KGaA; Takara Bio, Inc.; New England Biolabs; ThermoFisher Scientific, Inc.; and Waters Corporation.
Browse related reports by Grand View Research:
Live Cell Imaging Market - The global live cell imaging market size was valued at USD 4.5 billion in 2016 and is projected to grow with CAGR of 8.3% over the forecast period.
Protein Engineering Market - The global protein engineering market size was valued at 823.0 million in 2016 and is anticipated to grow at a CAGR of 15.9% throughout the forecast period.
Pharmaceutical Filtration Market - The global pharmaceutical filtration market size was estimated at USD 13.7 billion in 2016 and is expected to witness lucrative growth during the forecast period.
Cancer Biomarker Market - The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %.
Grand View Research has segmented the global glycomics/glycobiology market on the basis of product, application, end use, and region:
Glycomics/Glycobiology Product Outlook (Revenue, USD Million, 2014 - 2025)
Instruments
Mass Spectrometers
HPLC
MALDI-TOF
Array Systems
Others
Reagents
Glycoproteins
Monosaccharides
Oligosaccharides
Others
Kits
Glycan Labeling Kits
Glycan Purification Kits
Glycan Release Kits
Others
Enzymes
Glycosidases
Glycosyltransferases
Neuraminidases
Sialyltransferases
Others
Glycomics/Glycobiology Application Outlook (Revenue, USD Million, 2014 - 2025)
Drug Discovery & Development
Diagnostics
Others
Glycomics/Glycobiology End-Use Outlook (Revenue, USD Million, 2014 - 2025)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
CROs
Glycomics/Glycobiology Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Explore the BI enabled intuitive market research database,Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Veritas Technologies, the leader in secure multi-cloud data resilience, today announced artificial intelligence (AI)-powered advancements in Veritas 360 Defense. With the industry's first self-defending data protection solution, a generative...
Ouro, a global consumer financial services and technology innovator, and Bnext, a pioneering Spanish fintech, today announced a strategic partnership designating Bnext as Ouro's strategic issuer in Europe for Ouro's portfolio of consumer financial...
Dyno Therapeutics, Inc., a techbio company pioneering applications of artificial intelligence to engineer AAV capsids that expand the potential of genetic medicine, today announced a Scientific Symposium and the presentation of three research...
American Express Global Business Travel, which is operated by Global Business Travel Group, Inc. ("Amex GBT" or the "Company"), a leading B2B software and services company for travel and expense, today announced that it will report first quarter...
Grant Assistant today launched an AI-enhanced toolkit to simplify and streamline the complicated and time-consuming process of responding to solicitations. Grant Assistant provides a simple and structured workflow for preparing proposals for...
Prodoscore ("the Company"), a leader in employee visibility and productivity intelligence software, today published proprietary data exploring year over year employee productivity trends, including a 5% dip in productivity on Fridays compared to...